Emerald Advisers »

Corvus Pharmaceuticals shares owned by Emerald Advisers

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Emerald Advisers from 13F filings

Historical chart of Emerald Advisers investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Emerald Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $10M 686k 14.63

More positions owned by Emerald Advisers

Modine Manufacturing (MOD)
Guardant Health (GH)
Bloom Energy Corp (BE)
TTM Technologies (TTMI)
Cogent Biosciences (COGT)
Kratos Defense & Security Solutions (KTOS)
VSE Corporation (VSEC)
Fabrinet (FN)
Argan (AGX)
Aar (AIR)
Credo Technology Group Holding (CRDO)
Travere Therapeutics (TVTX)
ESCO Technologies (ESE)
Mercury Computer Systems (MRCY)
Livanova Plc Ord (LIVN)

View all positions for Emerald Advisers

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
BlackRock
Vanguard Group
Adams Street Partners
Vanguard Capital Management
Point72 Asset Management
State Street Corporation
MPM Oncology Impact Management
Vivo Capital
Geode Capital Management
Foresite Capital Management VI
Perceptive Advisors
Millennium Management
Emerald Advisers
Vanguard Portfolio Management

View all funds holding Corvus Pharmaceuticals